National Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, 28116, Republic of Korea.
Department of Biological Sciences, Chungnam National University, Daejeon, Republic of Korea.
Sci Rep. 2024 Feb 9;14(1):3352. doi: 10.1038/s41598-024-53648-2.
The CRISPR-Cas nickase system for genome editing has attracted considerable attention owing to its safety, efficiency, and versatility. Although alternative effectors to Cas9 have the potential to expand the scope of genome editing, their application has not been optimized. Herein, we used an enhanced CRISPR-Cas12a nickase system to induce mutations by targeting genes in a human-derived cell line. The optimized CRISPR-Cas12a nickase system effectively introduced mutations into target genes under a specific directionality and distance between nickases. In particular, the single-mode Cas12a nickase system can induce the target-specific mutations with less DNA double-strand breaks. By inducing mutations in the Thymine-rich target genes in single- or dual-mode, Cas12a nickase compensates the limitations of Cas9 nickase and is expected to contribute to the development of future genome editing technologies.
CRISPR-Cas 核酸酶系统因其安全性、效率和多功能性而引起了相当大的关注。虽然 Cas9 的替代效应物有可能扩大基因组编辑的范围,但它们的应用尚未得到优化。在这里,我们使用增强型 CRISPR-Cas12a 核酸酶系统通过靶向人源细胞系中的基因来诱导突变。优化后的 CRISPR-Cas12a 核酸酶系统可在特定的方向性和核酸酶之间的距离下有效地将突变引入靶基因。特别是,单模式 Cas12a 核酸酶系统可以在较少的 DNA 双链断裂下诱导靶基因特异性突变。通过在单模或双模中诱导胸腺嘧啶丰富的靶基因突变,Cas12a 核酸酶弥补了 Cas9 核酸酶的局限性,有望为未来的基因组编辑技术发展做出贡献。